nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

26.04.2022 | Review – Clinical Oncology

Role of ANO1 in tumors and tumor immunity

verfasst von: Haini Li, Zongxue Yu, Haiyan Wang, Ning Wang, Xueguo Sun, Shengmei Yang, Xu Hua, Zongtao Liu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Dysregulation of gene amplification, cell-signaling–pathway transduction, epigenetic and transcriptional regulation, and protein interactions drives tumor-cell proliferation and invasion, while ion channels also play an important role in the generation and development of tumor cells. Overexpression of Ca²⁺-activated Cl- channel anoctamin 1 (ANO1) is shown in numerous cancer types and correlates with poor prognosis. However, the mechanisms involved in ANO1-mediated malignant cellular transformation and the role of ANO1 in tumor immunity remain unknown. In this review, we discuss recent studies to determine the role of ANO1 in tumorigenesis and provide novel insights into the role of ANO1 in the context of tumor immunity. Furthermore, we analyze the roles and potential mechanisms of ANO1 in different types of cancers, and provide novel notions for the role of ANO1 in the tumor microenvironment and for potential use of ANO1 in clinical applications. Our review shows that ANO1 is involved in tumor immunity and microenvironment, and may, therefore, be an effective biomarker and therapeutic drug target.

Allison Stewart C, Tong P, Cardnell RJ, Sen T, Li L, Gay CM, Masrorpour F, Fan Y, Bara RO, Feng Y, Ru Y, Fujimoto J, Kundu ST, Post LE, Yu K, Shen Y, Glisson BS, Wistuba I, Heymach JV, Gibbons DL, Wang J, Byers LA (2017) Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer. Oncotarget 8:28575–28587PubMedCrossRef

Almaca J, Tian Y, Aldehni F, Ousingsawat J, Kongsuphol P, Rock JR, Harfe BD, Schreiber R, Kunzelmann K (2009) TMEM16 proteins produce volume-regulated chloride currents that are reduced in mice lacking TMEM16A. J Biol Chem 284:28571–28578PubMedPubMedCentralCrossRef

Apavaloaei A, Hardy MP, Thibault P, Perreault C (2020) The origin and immune recognition of tumor-specific antigens. Cancers (Basel) 12(9):2607

Avalos Prado P, Hafner S, Comoglio Y, Wdziekonski B, Duranton C, Attali B, Barhanin J, Sandoz G (2021) KCNE1 is an auxiliary subunit of two distinct ion channel superfamilies. Cell 184:534-544e11PubMedCrossRef

Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robe A, Roux M, Abecassis J, de Reynies A, Wasylyk B (2010) ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer 103:715–726PubMedPubMedCentralCrossRef

Bae JS, Park JY, Park SH, Ha SH, An AR, Noh SJ, Kwon KS, Jung SH, Park HS, Kang MJ, Jang KY (2018) Expression of ANO1/DOG1 is associated with shorter survival and progression of breast carcinomas. Oncotarget 9:607–621PubMedCrossRef

Bai W, Liu M, Xiao Q (2021) The diverse roles of TMEM16A Ca(2+)-activated Cl(-) channels in inflammation. J Adv Res 33:53–68PubMedPubMedCentralCrossRef

Bast RC Jr, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9:415–428PubMedPubMedCentralCrossRef

Bautista S, Theillet C (1998) CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei. Genes Chromosom Cancer 22:268–277PubMedCrossRef

Becchetti A, Munaron L, Arcangeli A (2013) The role of ion channels and transporters in cell proliferation and cancer. Front Physiol 4:312PubMedPubMedCentralCrossRef

Berglund E, Akcakaya P, Berglund D, Karlsson F, Vukojevic V, Lee L, Bogdanovic D, Lui WO, Larsson C, Zedenius J, Frobom R, Branstrom R (2014) Functional role of the Ca(2)(+)-activated Cl(-) channel DOG1/TMEM16A in gastrointestinal stromal tumor cells. Exp Cell Res 326:315–325PubMedCrossRef

Bill A, Hall ML, Borawski J, Hodgson C, Jenkins J, Piechon P, Popa O, Rothwell C, Tranter P, Tria S, Wagner T, Whitehead L, Gaither LA (2014) Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics. J Biol Chem 289:11029–11041PubMedPubMedCentralCrossRef

Bill A, Gutierrez A, Kulkarni S, Kemp C, Bonenfant D, Voshol H, Duvvuri U, Gaither LA (2015) ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Oncotarget 6:9173–9188PubMedPubMedCentralCrossRef

Bose T, Cieslar-Pobuda A, Wiechec E (2015) Role of ion channels in regulating Ca(2)(+) homeostasis during the interplay between immune and cancer cells. Cell Death Dis 6:e1648PubMedPubMedCentralCrossRef

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424PubMedCrossRef

Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M (2013) Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc Natl Acad Sci U S A 110:E1026–E1034PubMedPubMedCentralCrossRef

Brunner JD, Schenck S, Dutzler R (2016) Structural basis for phospholipid scrambling in the TMEM16 family. Curr Opin Struct Biol 39:61–70PubMedCrossRef

Cabrita I, Benedetto R, Fonseca A, Wanitchakool P, Sirianant L, Skryabin BV, Schenk LK, Pavenstadt H, Schreiber R, Kunzelmann K (2017) Differential effects of anoctamins on intracellular calcium signals. FASEB J 31:2123–2134PubMedCrossRef

Cao Q, Liu F, Ji K, Liu N, He Y, Zhang W, Wang L (2017) MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J Exp Clin Cancer Res CR 36:29PubMedCrossRef

Caputo A, Caci E, Ferrera L, Pedemonte N, Barsanti C, Sondo E, Pfeffer U, Ravazzolo R, Zegarra-Moran O, Galietta LJ (2008) TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 322:590–594PubMedCrossRef

Caputo A, Piano I, Demontis GC, Bacchi N, Casarosa S, Della Santina L, Gargini C (2015) TMEM16A is associated with voltage-gated calcium channels in mouse retina and its function is disrupted upon mutation of the auxiliary alpha2delta4 subunit. Front Cell Neurosci 9:422PubMedPubMedCentralCrossRef

Centeio R, Cabrita I, Benedetto R, Talbi K, Ousingsawat J, Schreiber R, Sullivan JK, Kunzelmann K (2020) Pharmacological inhibition and activation of the Ca(2+) activated Cl(-) channel TMEM16A. Int J Mol Sci 21(7):2557

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404PubMedCrossRef

Cha JY, Wee J, Jung J, Jang Y, Lee B, Hong GS, Chang BC, Choi YL, Shin YK, Min HY, Lee HY, Na TY, Lee MO, Oh U (2015) Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia. Proc Natl Acad Sci U S A 112:9722–9727PubMedPubMedCentralCrossRef

Chatterjee S, Browning EA, Hong N, DeBolt K, Sorokina EM, Liu W, Birnbaum MJ, Fisher AB (2012) Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. Am J Physiol Heart Circ Physiol 302:105–114CrossRef

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132PubMedCrossRef

Chenevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, Shiwarski D, Seethala RR (2012) DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol 25:919–929PubMedCrossRef

Cheng H, Yang S, Qu Z, Zhou S, Ruan Q (2016) Novel use for DOG1 in discriminating breast invasive carcinoma from noninvasive breast lesions. Dis Mark, p 5628176

Choi EJ, Yun JA, Jabeen S, Jeon EK, Won HS, Ko YH, Kim SY (2014) Prognostic significance of TMEM16A, PPFIA1, and FADD expression in invasive ductal carcinoma of the breast. World J Surg Oncol 12:137PubMedPubMedCentralCrossRef

Chou CY, Shen MR, Wu SN (1995) Volume-sensitive chloride channels associated with human cervical carcinogenesis. Can Res 55:6077–6083

Cipolletta E, Monaco S, Maione AS, Vitiello L, Campiglia P, Pastore L, Franchini C, Novellino E, Limongelli V, Bayer KU, Means AR, Rossi G, Trimarco B, Iaccarino G, Illario M (2010) Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology 151:2747–2759PubMedPubMedCentralCrossRef

Colon-Otero G, Weroha SJ, Foster NR, Haluska P, Hou X, Wahner-Hendrickson AE, Jatoi A, Block MS, Dinh TA, Robertson MW, Copland JA (2017) Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers. Gynecol Oncol 146:64–68PubMedCrossRef

Contreras-Vite JA, Cruz-Rangel S, De Jesus-Perez JJ, Figueroa IA, Rodriguez-Menchaca AA, Perez-Cornejo P, Hartzell HC, Arreola J (2016) Revealing the activation pathway for TMEM16A chloride channels from macroscopic currents and kinetic models. Pflugers Arch 468:1241–1257PubMedPubMedCentralCrossRef

Crottes D, Jan LY (2019) The multifaceted role of TMEM16A in cancer. Cell Calcium 82:102050PubMedPubMedCentralCrossRef

Crottes D, Lin YT, Peters CJ, Gilchrist JM, Wiita AP, Jan YN, Jan LY (2019) TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis. Proc Natl Acad Sci U S A 116:13026–13035PubMedPubMedCentralCrossRef

Cuddapah VA, Sontheimer H (2011) Ion channels and transporters [corrected] in cancer 2 Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 301:C541–C549PubMedPubMedCentralCrossRef

Dailey DD, Ehrhart EJ, Duval DL, Bass T, Powers BE (2015) DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors. J Vet Diagn Investig 27:268–277CrossRef

Danahay H, Fox R, Lilley S, Charlton H, Adley K, Christie L, Ansari E, Ehre C, Flen A, Tuvim MJ, Dickey BF, Williams C, Beaudoin S, Collingwood SP, Gosling M (2020) Potentiating TMEM16A does not stimulate airway mucus secretion or bronchial and pulmonary arterial smooth muscle contraction. FASEB Bioadv 2:464–477PubMedPubMedCentralCrossRef

Dang S, Feng S, Tien J, Peters CJ, Bulkley D, Lolicato M, Zhao J, Zuberbuhler K, Ye W, Qi L, Chen T, Craik CS, Jan YN, Minor DL Jr, Cheng Y, Jan LY (2017) Cryo-EM structures of the TMEM16A calcium-activated chloride channel. Nature 552:426–429PubMedPubMedCentralCrossRef

Danielsson J, Perez-Zoghbi J, Bernstein K, Barajas MB, Zhang Y, Kumar S, Sharma PK, Gallos G, Emala CW (2015) Antagonists of the TMEM16A calcium-activated chloride channel modulate airway smooth muscle tone and intracellular calcium. Anesthesiology 123:569–581PubMedCrossRef

Davies AR, Belsey MJ, Kozlowski RZ (2004) Volume-sensitive organic osmolyte/anion channels in cancer: novel approaches to studying channel modulation employing proteomics technologies. Ann N Y Acad Sci 1028:38–55PubMedCrossRef

De La Fuente R, Namkung W, Mills A, Verkman AS (2008) Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel. Mol Pharmacol 73:758–768CrossRef

Deng L, Yang J, Chen H, Ma B, Pan K, Su C, Xu F, Zhang J (2016) Knockdown of TMEM16A suppressed MAPK and inhibited cell proliferation and migration in hepatocellular carcinoma. Onco Targets Ther 9:325–333PubMedPubMedCentral

Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279–3290PubMedCrossRef

Dixit R, Kemp C, Kulich S, Seethala R, Chiosea S, Ling S, Ha PK, Duvvuri U (2015) TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation. Sci Rep 5:16657PubMedPubMedCentralCrossRef

Dmitrieva OS, Shilovskiy IP, Khaitov MR, Grivennikov SI (2016) Interleukins 1 and 6 as Main Mediators of Inflammation and Cancer. Biochemistry (mosc) 81:80–90CrossRef

Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, Rock JR, Harfe BD, Henson BJ, Kunzelmann K, Schreiber R, Seethala RS, Egloff AM, Chen X, Lui VW, Grandis JR, Gollin SM (2012) TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Can Res 72:3270–3281CrossRef

Filippou A, Pehkonen H, Karhemo PR, Vaananen J, Nieminen AI, Klefstrom J, Grenman R, Makitie AA, Joensuu H, Monni O (2012) ANO1 Expression orchestrates p27Kip1/MCL1-mediated signaling in head and neck squamous cell carcinoma. Cancers (Basel) 13(5):1170

Finegersh A, Kulich S, Guo T, Favorov AV, Fertig EJ, Danilova LV, Gaykalova DA, Califano JA, Duvvuri U (2017) DNA methylation regulates TMEM16A/ANO1 expression through multiple CpG islands in head and neck squamous cell carcinoma. Sci Rep 7:15173PubMedPubMedCentralCrossRef

Frede J, Fraser SP, Oskay-Ozcelik G, Hong Y, Ioana Braicu E, Sehouli J, Gabra H, Djamgoz MB (2013) Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential. Eur J Cancer 49:2331–2344PubMedCrossRef

Frobom R, Sellberg F, Xu C, Zhao A, Larsson C, Lui WO, Nilsson IL, Berglund E, Branstrom R (2019) Biochemical inhibition of DOG1/TMEM16A achieves antitumoral effects in human gastrointestinal stromal tumor cells in vitro. Anticancer Res 39:3433–3442PubMedCrossRef

Fujimoto M, Inoue T, Kito H, Niwa S, Suzuki T, Muraki K, Ohya S (2017) Transcriptional repression of HER2 by ANO1 Cl(-) channel inhibition in human breast cancer cells with resistance to trastuzumab. Biochem Biophys Res Commun 482:188–194PubMedCrossRef

Fujimoto M, Kito H, Kajikuri J, Ohya S (2018) Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl(-) /H(+) transporter inhibition in human breast cancer cells. Cancer Sci 109:2781–2791PubMedPubMedCentralCrossRef

Furst J, Gschwentner M, Ritter M, Botta G, Jakab M, Mayer M, Garavaglia L, Bazzini C, Rodighiero S, Meyer G, Eichmuller S, Woll E, Paulmichl M (2002) Molecular and functional aspects of anionic channels activated during regulatory volume decrease in mammalian cells. Pflugers Arch 444:1–25PubMedCrossRef

Gasparotto D, Sbaraglia M, Rossi S, Baldazzi D, Brenca M, Mondello A, Nardi F, Racanelli D, Cacciatore M, Paolo Dei Tos A, Maestro R (2020) Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumors. JCI insight 5(22):e142560

Godse NR, Khan N, Yochum ZA, Gomez-Casal R, Kemp C, Shiwarski DJ, Seethala RS, Kulich S, Seshadri M, Burns TF, Duvvuri U (2017) TMEM16A/ANO1 inhibits apoptosis via downregulation of Bim expression. Clin Cancer Res 23:7324–7332PubMedPubMedCentralCrossRef

Guan L, Song Y, Gao J, Gao J, Wang K (2016) Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells. Oncotarget 7:78619–78630PubMedPubMedCentralCrossRef

Guo S, Chen Y, Pang C, Wang X, Shi S, Zhang H, An H, Zhan Y (2019) Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects. J Cell Physiol 234:8698–8708PubMedCrossRef

Habela CW, Ernest NJ, Swindall AF, Sontheimer H (2009) Chloride accumulation drives volume dynamics underlying cell proliferation and migration. J Neurophysiol 101:750–757PubMedCrossRef

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674PubMedCrossRef

Hara K, Kondo M, Tsuji M, Takeyama K, Tamaoki J (2019) Clarithromycin suppresses IL-13-induced goblet cell metaplasia via the TMEM16A-dependent pathway in guinea pig airway epithelial cells. Respir Investig 57:79–88PubMedCrossRef

Harper CM, Fukodome T, Engel AG (2003) Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology 60:1710–1713PubMedCrossRef

Hartzell C, Putzier I, Arreola J (2005) Calcium-activated chloride channels. Annu Rev Physiol 67:719–758PubMedCrossRef

Hinshaw DC, Shevde LA (2019) The Tumor Microenvironment Innately Modulates Cancer Progression. Can Res 79:4557–4566CrossRef

Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:86PubMedPubMedCentralCrossRef

Hong GS, Lee SH, Lee B, Choi JH, Oh SJ, Jang Y, Hwang EM, Kim H, Jung J, Kim IB, Oh U (2019) ANO1/TMEM16A regulates process maturation in radial glial cells in the developing brain. Proc Natl Acad Sci U S A 116:12494–12499PubMedPubMedCentralCrossRef

Huang X, Gollin SM, Raja S, Godfrey TE (2002) High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A 99:11369–11374PubMedPubMedCentralCrossRef

Huang X, Godfrey TE, Gooding WE, McCarty KS Jr, Gollin SM (2006) Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosom Cancer 45:1058–1069PubMedCrossRef

Iqbal J, Tonta MA, Mitsui R, Li Q, Kett M, Li J, Parkington HC, Hashitani H, Lang RJ (2012) Potassium and ANO1/ TMEM16A chloride channel profiles distinguish atypical and typical smooth muscle cells from interstitial cells in the mouse renal pelvis. Br J Pharmacol 165:2389–2408PubMedPubMedCentralCrossRef

Jentsch TJ (2016) VRACs and other ion channels and transporters in the regulation of cell volume and beyond. Nat Rev Mol Cell Biol 17:293–307PubMedCrossRef

Ji Q, Guo S, Wang X, Pang C, Zhan Y, Chen Y, An H (2019) Recent advances in TMEM16A: structure, function, and disease. J Cell Physiol 234:7856–7873PubMedCrossRef

Jia L, Liu W, Guan L, Lu M, Wang K (2015) Inhibition of calcium-activated chloride channel ANO1/TMEM16A suppresses tumor growth and invasion in human lung cancer. PLoS ONE 10:e0136584PubMedPubMedCentralCrossRef

Jiang W, Cheng Y, Zhao N, Li L, Shi Y, Zong A, Wang F (2018) Sulfated polysaccharide of Sepiella maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTOR signaling pathways in SKOV-3 cells. Int J Biol Macromol 107:349–362PubMedCrossRef

Jiang Y, Cai Y, Shao W, Li F, Guan Z, Zhou Y, Tang C, Feng S (2019) MicroRNA-144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer. Oncol Rep 41:2361–2370PubMed

Jones PA, Issa JP, Baylin S (2016) Targeting the cancer epigenome for therapy. Nat Rev Genet 17:630–641PubMedCrossRef

Jung J, Nam JH, Park HW, Oh U, Yoon JH, Lee MG (2013) Dynamic modulation of ANO1/TMEM16A HCO3(-) permeability by Ca2+/calmodulin. Proc Natl Acad Sci U S A 110:360–365PubMedCrossRef

Kane Dickson V, Pedi L, Long SB (2014) Structure and insights into the function of a Ca(2+)-activated Cl(-) channel. Nature 516:213–218PubMedCrossRef

Kang JW, Lee YH, Kang MJ, Lee HJ, Oh R, Min HJ, Namkung W, Choi JY, Lee SN, Kim CH, Yoon JH, Cho HJ (2017) Synergistic mucus secretion by histamine and IL-4 through TMEM16A in airway epithelium. Am J Physiol Lung Cell Mol Physiol 313:L466–L476PubMedCrossRef

Kim JY, Youn HY, Choi J, Baek SK, Kwon SY, Eun BK, Park JY, Oh KH (2019) Anoctamin-1 affects the migration and invasion of anaplastic thyroid carcinoma cells. Anim Cells Syst (seoul) 23:294–301CrossRef

Ko EA, Jin BJ, Namkung W, Ma T, Thiagarajah JR, Verkman AS (2014) Chloride channel inhibition by a red wine extract and a synthetic small molecule prevents rotaviral secretory diarrhoea in neonatal mice. Gut 63:1120–1129PubMedCrossRef

Kondo M, Tsuji M, Hara K, Arimura K, Yagi O, Tagaya E, Takeyama K, Tamaoki J (2017) Chloride ion transport and overexpression of TMEM16A in a guinea-pig asthma model. Clin Exp Allergy 47:795–804PubMedCrossRef

Kraus A, Schley G, Kunzelmann K, Schreiber R, Peters DJ, Stadler R, Eckardt KU, Buchholz B (2016) Glucose promotes secretion-dependent renal cyst growth. J Mol Med (berl) 94:107–117CrossRef

Kulkarni S, Bill A, Godse NR, Khan NI, Kass JI, Steehler K, Kemp C, Davis K, Bertrand CA, Vyas AR, Holt DE, Grandis JR, Gaither LA, Duvvuri U (2017) TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2. Genes Chromosom Cancer 56:460–471PubMedCrossRef

Kunzelmann K, Ousingsawat J, Benedetto R, Cabrita I, Schreiber R (2019) Contribution of anoctamins to cell survival and cell death. Cancers (Basel) 11(3):382

Lee CH, Liang CW, Espinosa I (2010) The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it. Adv Anat Pathol 17:222–232PubMedCrossRef

Lee YH, Yi GS (2018) Prediction of novel anoctamin1 (ANO1) inhibitors using 3D-QSAR pharmacophore modeling and molecular docking. Int J Mol Sci 19(10):3204

Lee YS, Lee JK, Bae Y, Lee BS, Kim E, Cho CH, Ryoo K, Yoo J, Kim CH, Yi GS, Lee SG, Lee CJ, Kang SS, Hwang EM, Park JY (2016) Suppression of 14-3-3gamma-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells. Sci Rep 6:26413PubMedPubMedCentralCrossRef

Li Y, Zhang J, Hong S (2014) ANO1 as a marker of oral squamous cell carcinoma and silencing ANO1 suppresses migration of human scc-25 cells. Medicina Oral Patología Oral y Cirugia Bucal 9(4):e313–e319

Li Q, Zhi X, Zhou J, Tao R, Zhang J, Chen P, Roe OD, Sun L, Ma L (2016) Circulating tumor cells as a prognostic and predictive marker in gastrointestinal stromal tumors: a prospective study. Oncotarget 7:36645–36654PubMedPubMedCentralCrossRef

Li H, Wu A, Zhu W, Hou F, Cheng S, Cao J, Yan Y, Zhang C, Liu Z (2019) Detection of ANO1 mRNA in PBMCs is a promising method for GISTs diagnosis. Sci Rep 9:9525PubMedPubMedCentralCrossRef

Li H, Yang Q, Huo S, Du Z, Wu F, Zhao H, Chen S, Yang L, Ma Z, Sui Y (2021) Expression of TMEM16A in colorectal cancer and its correlation with clinical and pathological parameters. Front Oncol 11:652262PubMedPubMedCentralCrossRef

Lian H, Cheng Y, Wu X (2017) TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice. Biochem Biophys Res Commun 487:201–208PubMedCrossRef

Lin H, Hu C, Zheng S, Zhang X, Chen R, Zhou Q (2021) A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer. Aging (albany NY) 13:12493–12513CrossRef

Liu CL, Shi GP (2019) Calcium-activated chloride channel regulator 1 (CLCA1): More than a regulator of chloride transport and mucus production. World Allergy Organ J 12:100077PubMedPubMedCentralCrossRef

Liu W, Lu M, Liu B, Huang Y, Wang K (2012) Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. Cancer Lett 326:41–51PubMedCrossRef

Liu J, Liu Y, Ren Y, Kang L, Zhang L (2014) Transmembrane protein with unknown function 16A overexpression promotes glioma formation through the nuclear factor-kappaB signaling pathway. Mol Med Rep 9:1068–1074PubMedCrossRef

Liu F, Cao QH, Lu DJ, Luo B, Lu XF, Luo RC, Wang XG (2015) TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-beta signaling. Oncotarget 6:11585–11599PubMedPubMedCentralCrossRef

Liu Z, Zhang S, Hou F, Zhang C, Gao J, Wang K (2018) Inhibition of Ca(2+) -activated chloride channel ANO1 suppresses ovarian cancer through inactivating PI3K/Akt signaling. Int J Cancer 144:2215–2226

Liu Z, Zhang S, Hou F, Zhang C, Gao J, Wang K (2019) Inhibition of Ca(2+) -activated chloride channel ANO1 suppresses ovarian cancer through inactivating PI3K/Akt signaling. Int J Cancer 144:2215–2226PubMedCrossRef

Liu Y, Liu Z, Wang K (2021) The Ca(2+)-activated chloride channel ANO1/TMEM16A: an emerging therapeutic target for epithelium-originated diseases? Acta Pharm Sin B 11:1412–1433PubMedCrossRef

Lu P, Xu M, Xiong Z, Zhou F, Wang L (2019) Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway. Cancer Manag Res 11:9057–9066PubMedPubMedCentralCrossRef

Luo S, Wang H, Bai L, Chen Y, Chen S, Gao K, Wang H, Wu S, Song H, Ma K, Liu M, Yao F, Fang Y, Xiao Q (2021) Activation of TMEM16A Ca(2+)-activated Cl(-) channels by ROCK1/moesin promotes breast cancer metastasis. J Adv Res 33:253–264PubMedPubMedCentralCrossRef

Matsuba S, Niwa S, Muraki K, Kanatsuka S, Nakazono Y, Hatano N, Fujii M, Zhan P, Suzuki T, Ohya S (2014) Downregulation of Ca2+-activated Cl- channel TMEM16A by the inhibition of histone deacetylase in TMEM16A-expressing cancer cells. J Pharmacol Exp Ther 351:510–518PubMedCrossRef

Mazzone A, Eisenman ST, Strege PR, Yao Z, Ordog T, Gibbons SJ, Farrugia G (2012) Inhibition of cell proliferation by a selective inhibitor of the Ca(2+)-activated Cl(-) channel, Ano1. Biochem Biophys Res Commun 427:248–253PubMedPubMedCentralCrossRef

Mazzone A, Gibbons SJ, Bernard CE, Nowsheen S, Middha S, Almada LL, Ordog T, Kendrick ML, Reid Lombardo KM, Shen KR, Galietta LJ, Fernandez-Zapico ME, Farrugia G (2015) Identification and characterization of a novel promoter for the human ANO1 gene regulated by the transcription factor signal transducer and activator of transcription 6 (STAT6). FASEB J 29:152–163PubMedCrossRef

Miner K, Labitzke K, Liu B, Wang P, Henckels K, Gaida K, Elliott R, Chen JJ, Liu L, Leith A, Trueblood E, Hensley K, Xia XZ, Homann O, Bennett B, Fiorino M, Whoriskey J, Yu G, Escobar S, Wong M, Born TL, Budelsky A, Comeau M, Smith D, Phillips J, Johnston JA, McGivern JG, Weikl K, Powers D, Kunzelmann K, Mohn D, Hochheimer A, Sullivan JK (2019) Drug repurposing: the anthelmintics niclosamide and nitazoxanide are potent TMEM16A antagonists that fully bronchodilate airways. Front Pharmacol 10:51PubMedPubMedCentralCrossRef

Mirzaei S, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Ranjbar A, Seyed Saleh SH, Bagherian M, Sharifzadeh SO, Hushmandi K, Liskova A, Kubatka P, Makvandi P, Tergaonkar V, Kumar AP, Ashrafizadeh M, Sethi G (2021) Regulation of Nuclear Factor-KappaB (NF-kappaB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? Cancer Lett 509:63–80PubMedCrossRef

Mokutani Y, Uemura M, Munakata K, Okuzaki D, Haraguchi N, Takahashi H, Nishimura J, Hata T, Murata K, Takemasa I, Mizushima T, Doki Y, Mori M, Yamamoto H (2016) Down-regulation of microRNA-132 is associated with poor prognosis of colorectal cancer. Ann Surg Oncol 23:599–608PubMedPubMedCentralCrossRef

Morris LGT, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL (2017) The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform. JAMA Oncol 3:244–255PubMedPubMedCentralCrossRef

Namkung W, Thiagarajah JR, Phuan PW, Verkman AS (2010) Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea. FASEB J 24:4178–4186PubMedPubMedCentralCrossRef

Namkung W, Phuan PW, Verkman AS (2011) TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J Biol Chem 286:2365–2374PubMedCrossRef

Okada Y, Maeno E, Shimizu T, Manabe K, Mori S, Nabekura T (2004) Dual roles of plasmalemmal chloride channels in induction of cell death. Pflugers Arch 448:287–295PubMedCrossRef

Pang C, Yuan H, Ren S, Chen Y, An H, Zhan Y (2014) TMEM16A/B associated CaCC: structural and functional insights. Protein Pept Lett 21:94–99PubMedCrossRef

Park YR, Lee ST, Kim SL, Zhu SM, Lee MR, Kim SH, Kim IH, Lee SO, Seo SY, Kim SW (2019) Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Cancer Genet 231–232:22–31PubMedCrossRef

Paulino C, Kalienkova V, Lam AKM, Neldner Y, Dutzler R (2017) Activation mechanism of the calcium-activated chloride channel TMEM16A revealed by cryo-EM. Nature 552:421–425PubMedCrossRef

Pearson H, Todd E, Ahrends M, Hover SE, Whitehouse A, Stacey M, Lippiat JD, Wilkens L, Fieguth HG, Danov O, Hesse C, Barr JN, Mankouri J (2021) TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection. Thorax 76:64–72PubMedCrossRef

Pinto MC, Schreiber R, Lerias J, Ousingsawat J, Duarte A, Amaral M, Kunzelmann K (2020) Regulation of TMEM16A by CK2 and its role in cellular proliferation. Cells 9

Qin Y, Jiang Y, Sheikh AS, Shen S, Liu J, Jiang D (2016) Interleukin-13 stimulates MUC5AC expression via a STAT6-TMEM16A-ERK1/2 pathway in human airway epithelial cells. Int Immunopharmacol 40:106–114PubMedCrossRef

Qu Z, Yao W, Yao R, Liu X, Yu K, Hartzell C (2014) The Ca(2+) -activated Cl(-) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis. Cancer Med 3:453–461PubMedPubMedCentralCrossRef

Reddy RB, Bhat AR, James BL, Govindan SV, Mathew R, Ravindra DR, Hedne N, Illiayaraja J, Kekatpure V, Khora SS, Hicks W, Tata P, Kuriakose MA, Suresh A (2016) Meta-analyses of microarray datasets identifies ANO1 and FADD as prognostic markers of head and neck cancer. PLoS ONE 11:e0147409PubMedPubMedCentralCrossRef

Rodrigo JP, Menéndez ST, Hermida-Prado F, Álvarez-Teijeiro S, Villaronga M, Alonso-Durán L, Vallina A, Martínez-Camblor P, Astudillo A, Suárez C, María García-Pedrero J (2015) Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas. Sci Rep 5:15698PubMedPubMedCentralCrossRef

Ruiz C, Martins JR, Rudin F, Schneider S, Dietsche T, Fischer CA, Tornillo L, Terracciano LM, Schreiber R, Bubendorf L, Kunzelmann K (2012) Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. PLoS ONE 7:e43265PubMedPubMedCentralCrossRef

Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16:203–222PubMedCrossRef

Salomon JJ, Albrecht T, Graeber SY, Scheuermann H, Butz S, Schatterny J, Mairbaurl H, Baumann I, Mall MA (2021) Chronic rhinosinusitis with nasal polyps is associated with impaired TMEM16A-mediated epithelial chloride secretion. J Allergy Clin Immunol 147:2191-2201e2PubMedCrossRef

Sauter DRP, Novak I, Pedersen SF, Larsen EH, Hoffmann EK (2015) ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC). Pflugers Arch 467:1495–1508PubMedCrossRef

Schmitt JM, Smith S, Hart B, Fletcher L (2012) CaM kinase control of AKT and LNCaP cell survival. J Cell Biochem 113:1514–1526PubMed

Schroeder BC, Cheng T, Jan YN, Jan LY (2008) Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 134:1019–1029PubMedPubMedCentralCrossRef

Schwab A, Fabian A, Hanley PJ, Stock C (2012) Role of ion channels and transporters in cell migration. Physiol Rev 92:1865–1913PubMedCrossRef

Seo Y, Park J, Kim M, Lee HK, Kim JH, Jeong JH, Namkung W (2015) Inhibition of ANO1/TMEM16A chloride channel by idebenone and its cytotoxicity to cancer cell lines. PLoS ONE 10:e0133656PubMedPubMedCentralCrossRef

Seo Y, Kim J, Chang J, Kim SS, Namkung W, Kim I (2018) Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors. Eur J Med Chem 160:245–255PubMedCrossRef

Seo Y, Anh NH, Heo Y, Park SH, Kiem PV, Lee Y, Yen DTH, Jo S, Jeon D, Tai BH, Nam NH, Minh CV, Kim SH, Nhiem NX, Namkung W (2020) Novel ANO1 inhibitor from Mallotus apelta extract exerts anticancer activity through downregulation of ANO1. Int J Mol Sci 21(18):6470

Shi ZZ, Shang L, Jiang YY, Hao JJ, Zhang Y, Zhang TT, Lin DC, Liu SG, Wang BS, Gong T, Zhan QM, Wang MR (2013) Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization. Clin Cancer Res 19:5867–5878PubMedCrossRef

Shiwarski DJ, Shao C, Bill A, Kim J, Xiao D, Bertrand CA, Seethala RS, Sano D, Myers JN, Ha P, Grandis J, Gaither LA, Puthenveedu MA, Duvvuri U (2014) To “grow” or “go”: TMEM16A expression as a switch between tumor growth and metastasis in SCCHN. Clin Cancer Res 20:4673–4688PubMedPubMedCentralCrossRef

Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30PubMedCrossRef

Siegel RL, Miller KD, Jemal A (2018) Cancer statistics. CA Cancer J Clin 68(2018):7–30PubMedCrossRef

Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics. CA Cancer J Clin 71(2021):7–33PubMedCrossRef

Simon S, Grabellus F, Ferrera L, Galietta L, Schwindenhammer B, Muhlenberg T, Taeger G, Eilers G, Treckmann J, Breitenbuecher F, Schuler M, Taguchi T, Fletcher JA, Bauer S (2013) DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors. Can Res 73:3661–3670CrossRef

Song Y, Gao J, Guan L, Chen X, Gao J, Wang K (2018) Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-alpha signaling. Cell Death Dis 9:703PubMedPubMedCentralCrossRef

Steelman LS, Fitzgerald T, Lertpiriyapong K, Cocco L, Follo MY, Martelli AM, Neri LM, Marmiroli S, Libra M, Candido S, Nicoletti F, Scalisi A, Fenga C, Drobot L, Rakus D, Gizak A, Laidler P, Dulinska-Litewka J, Basecke J, Mijatovic S, Maksimovic-Ivanic D, Montalto G, Cervello M, Milella M, Tafuri A, Demidenko Z, Abrams SL, McCubrey JA (2016) Critical roles of EGFR family members in breast cancer and breast cancer stem cells: targets for therapy. Curr Pharm Des 22:2358–2388PubMedCrossRef

Sui Y, Sun M, Wu F, Yang L, Di W, Zhang G, Zhong L, Ma Z, Zheng J, Fang X, Ma T (2014) Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells. PLoS ONE 9:e115443PubMedPubMedCentralCrossRef

Suzuki A, Leland P, Joshi BH, Puri RK (2015) Targeting of IL-4 and IL-13 receptors for cancer therapy. Cytokine 75:79–88PubMedCrossRef

Svenningsen P, Nielsen MR, Marcussen N, Walter S, Jensen BL (2014) TMEM16A is a Ca(2+) -activated Cl(-) channel expressed in the renal collecting duct. Acta Physiol 212:166–174CrossRef

Takayama Y, Uta D, Furue H, Tominaga M (2015) Pain-enhancing mechanism through interaction between TRPV1 and anoctamin 1 in sensory neurons. Proc Natl Acad Sci U S A 112:5213–5218PubMedPubMedCentralCrossRef

Ubby I, Bussani E, Colonna A, Stacul G, Locatelli M, Scudieri P, Galietta L, Pagani F (2013) TMEM16A alternative splicing coordination in breast cancer. Mol Cancer 12:75PubMedPubMedCentralCrossRef

Vanoni S, Zeng C, Marella S, Uddin J, Wu D, Arora K, Ptaschinski C, Que J, Noah T, Waggoner L, Barski A, Kartashov A, Rochman M, Wen T, Martin L, Spence J, Collins M, Mukkada V, Putnam P, Naren A, Chehade M, Rothenberg ME, Hogan SP (2020) Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis. J Allergy Clin Immunol 145:239-254e2PubMedCrossRef

Veit G, Bossard F, Goepp J, Verkman AS, Galietta LJ, Hanrahan JW, Lukacs GL (2012) Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia. Mol Biol Cell 23:4188–4202PubMedPubMedCentralCrossRef

Wang H, Zou L, Ma K, Yu J, Wu H, Wei M, Xiao Q (2017) Cell-specific mechanisms of TMEM16A Ca(2+)-activated chloride channel in cancer. Mol Cancer 16:152PubMedPubMedCentralCrossRef

Wang H, Yao F, Luo S, Ma K, Liu M, Bai L, Chen S, Song C, Wang T, Du Q, Wu H, Wei M, Fang Y, Xiao Q (2019) A mutual activation loop between the Ca(2+)-activated chloride channel TMEM16A and EGFR/STAT3 signaling promotes breast cancer tumorigenesis. Cancer Lett 455:48–59PubMedCrossRef

Wang Y, Xiang Y, Xin VW, Wang XW, Peng XC, Liu XQ, Wang D, Li N, Cheng JT, Lyv YN, Cui SZ, Ma Z, Zhang Q, Xin HW (2020) Dendritic cell biology and its role in tumor immunotherapy. J Hematol Oncol 13:107PubMedPubMedCentralCrossRef

Wanitchakool P, Wolf L, Koehl GE, Sirianant L, Schreiber R, Kulkarni S, Duvvuri U, Kunzelmann K (2014) Role of anoctamins in cancer and apoptosis. Philos Trans R Soc Lond B Biol Sci 369:20130096PubMedPubMedCentralCrossRef

West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M (2004) The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165:107–113PubMedPubMedCentralCrossRef

Wu H, Guan S, Sun M, Yu Z, Zhao L, He M, Zhao H, Yao W, Wang E, Jin F, Xiao Q, Wei M (2015) Ano1/TMEM16A overexpression is associated with good prognosis in PR-positive or HER2-negative breast cancer patients following tamoxifen treatment. PLoS ONE 10:e0126128PubMedPubMedCentralCrossRef

Wu H, Wang H, Guan S, Zhang J, Chen Q, Wang X, Ma K, Zhao P, Zhao H, Yao W, Jin F, Xiao Q, Wei M (2017) Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status. Oncotarget 8:84996–85013PubMedPubMedCentralCrossRef

Xu H, Chen L, Shao Y, Zhu D, Zhi X, Zhang Q, Li F, Xu J, Liu X, Xu Z (2018) Clinical application of circulating tumor DNA in the genetic analysis of patients with advanced GIST. Mol Cancer Ther 17:290–296PubMedCrossRef

Yang YD, Cho H, Koo JY, Tak MH, Cho Y, Shim WS, Park SP, Lee J, Lee B, Kim BM, Raouf R, Shin YK, Oh U (2008) TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 455:1210–1215PubMedCrossRef

Yano S, Tokumitsu H, Soderling TR (1998) Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396:584–587PubMedCrossRef

Yi M, Zhang LJ, Liu XJ, Wang N, Huang CN, Liu MQ, Chang SH, Liu WD, Yang L (2021) Increased serum IL-27 concentrations and IL-27-producing cells in MG patients with positive AChR-Ab. J Clin Neurosci 86:289–293PubMedCrossRef

Yu B, Zhu X, Yang X, Jin L, Xu J, Ma T, Yang H (2019) Plumbagin prevents secretory diarrhea by inhibiting CaCC and CFTR channel activities. Front Pharmacol 10:1181PubMedPubMedCentralCrossRef

Yu Y, Li Z, Huang C, Fang H, Zhao F, Zhou Y, Pan X, Li Q, Zhuang Y, Chen L, Xu J, Wang W (2020) Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer. Cancer Med 9:575–585PubMedCrossRef

Zeng X, Pan D, Wu H, Chen H, Yuan W, Zhou J, Shen Z, Chen S (2019) Transcriptional activation of ANO1 promotes gastric cancer progression. Biochem Biophys Res Commun 512:131–136PubMedCrossRef

Zhang Y, Wang X, Wang H, Jiao J, Li Y, Fan E, Zhang L, Bachert C (2015) TMEM16A-mediated mucin secretion in IL-13-induced nasal epithelial cells from chronic rhinosinusitis patients. Allergy Asthma Immunol Res 7:367–375PubMedPubMedCentralCrossRef

Zhang H, Shang YP, Chen HY, Li J (2017) Histone deacetylases function as novel potential therapeutic targets for cancer. Hepatol Res 47:149–159PubMedCrossRef

Zhang C, Liu J, Han Z, Cui X, Peng D, Xing Y (2020a) Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma. Int J Clin Oncol 25:1145–1154PubMedCrossRef

Zhang X, Zhang G, Zhai W, Zhao Z, Wang S, Yi J (2020b) Inhibition of TMEM16A Ca(2+)-activated Cl(-) channels by avermectins is essential for their anticancer effects. Pharmacol Res 156:104763PubMedCrossRef

Zhang C, Li H, Gao J, Cui X, Yang S, Liu Z (2021) Prognostic significance of ANO1 expression in cancers. Medicine (baltimore) 100:e24525CrossRef

Titel: Role of ANO1 in tumors and tumor immunity
verfasst von: Haini Li
Zongxue Yu
Haiyan Wang
Ning Wang
Xueguo Sun
Shengmei Yang
Xu Hua
Zongtao Liu
Publikationsdatum: 26.04.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2022
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-022-04004-2

Springer Medizin

Role of ANO1 in tumors and tumor immunity

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma

Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2

Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy

Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary

Regulatory network identified by pulmonary transcriptome and proteome profiling reveals extensive change of tumor-related genes in microRNA-21 knockout mice

Transformation of invasive lung adenocarcinoma with ALK rearrangement into pulmonary sarcomatoid carcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie